Cipla announced that it has entered into an exclusive marketing and distribution agreement with US-based MannKind Corporation for Afrezza in India. Afrezza is the only USFDA approved inhaled insulin available for patients suffering from diabetes. The announcement was made after market hours yesterday, 9 May 2018.
Afrezza, an inhaled insulin, is a cutting-edge product which will increase patient convenience, said Umang Vohra, MD & Global CEO, Cipla. The innovative drug delivery system will revolutionize the diabetic care in India.
Eicher Motors' consolidated net profit rose 0.45% to Rs 461.53 crore on 35.05% rise in total income to Rs 2709.21 crore in Q4 March 2018 over Q4 March 2017. The announcement was made after market hours yesterday, 9 May 2018.
Avanti Feeds' board of directors has approved a 2-for-1 stock split and a 1:2 bonus issue of shares. The announcement was made after market hours yesterday, 9 May 2018.
Hikal's board of directors has approved a 1:2 bonus issue of shares. The announcement was made after market hours yesterday, 9 May 2018.
Reliance Infrastructure has scheduled a board meeting on 14 May 2018 inter alia, to consider augmenting long term resources by issue of equity shares by way of rights issue and/or qualified institutions placement. The announcement was made after market hours yesterday, 9 May 2018.
More From This Section
Adani Enterprises, Asian Paints, Nestle India, Tata Communications, Titan Company, Union Bank of India and Zee Entertainment Enterprises will announce January-March 2018 quarterly results today, 10 May 2018.
Powered by Capital Market - Live News